Five-year relative survival for human papillomavirus-associated cancer sites.

about

Five-year relative survival for human papillomavirus-associated cancer sites.

Item

http://www.wikidata.org/entity/Q47589931

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Five-year relative survival for human papillomavirus-associated cancer sites.

@en

Five-year relative survival for human papillomavirus-associated cancer sites.

@nl

type

Item

label

Five-year relative survival for human papillomavirus-associated cancer sites.

@en

Five-year relative survival for human papillomavirus-associated cancer sites.

@nl

prefLabel

Five-year relative survival for human papillomavirus-associated cancer sites.

@en

Five-year relative survival for human papillomavirus-associated cancer sites.

@nl

P1476

Five-year relative survival for human papillomavirus-associated cancer sites

@en

P2093

Laura Viens

http://www.w3.org/2001/XMLSchema#string

Mona Saraiya

http://www.w3.org/2001/XMLSchema#string

Trevor D Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Human papillomavirus and survival of patients with oropharyngeal cancer.

Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007.

Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program.

Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States

Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.

Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Interpreting trends in cancer patient survival.

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.

P304

203-211

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30947

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

S Jane Henley

Hilda Razzaghi

Reda Wilson

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29105738

http://www.w3.org/2001/XMLSchema#string

P932

5793215

http://www.w3.org/2001/XMLSchema#string